European Medicines Agency appeals Brexit “frustration” ruling

EMA Canary Wharf

The European Medicines Agency (EMA) has appealed the High Court’s ruling that Brexit did not amount to the legal “frustration” of its £500m, 25-year lease with Canary Wharf Group.

The agency was given leave to appeal last month and submitted its appeal just before its deadline on Monday 15 April.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article.

Sign up now for the following benefits:

  • Four FREE articles of your choice per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.

Registered users and subscribers SIGN IN here to continue